| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 17, 2012Published data demonstrate the Symplicity(TM) renal denervation system provides blood pressure reduction in patients with treatment-resistant hypertension sustained to 12 months
MINNEAPOLIS - December 17, 2012 - Medtronic, Inc. (NYSE: MDT) today announced that one-year results from Symplicity HTN-2, the first randomized clinical trial investigating renal denervation, were...
-
Dec 12, 2012
MINNEAPOLIS - Dec 4, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer 23rd Annual Healthcare Conference on...
-
Dec 10, 2012
MINNEAPOLIS - Dec 10, 2012 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the JP Morgan 31st Annual Healthcare Conference on...
-
Dec 6, 2012
MEMPHIS, Tenn. - Dec. 6, 2012 - Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced the U.S. launch of the company's latest addition to their cervical surgical technique...
-
Dec 6, 2012
MINNEAPOLIS - December 6, 2012 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on...